Definium Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$22.05

-1.15 (-4.96%)

As of May 10, 10:06 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 21 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +108.6% upside

Low Target $39.37

Average Target $46.00

High Target $57.04

Current Price $22.05

Current
$22.05

Target
$46.00

$39.37 $46.00 avg $57.04

Scenario Analysis

Bear Case

$39.37

78.5%

Low target

Base Case

$46.00

+108.6%

Avg target

Bull Case

$57.04

+158.7%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$26.25

-16.0% from high

52-Week Low

$6.03

+265.7% from low

Target vs 52W High

$46.00

+75.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	36	44%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%